Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716–724. https://doi.org/10.1016/j.chom.2018.05.003

Article  CAS  PubMed  Google Scholar 

Allam AR, Helal MB, Alhateem MS et al (2025) Network meta-analysis of randomized control trials evaluating the effectiveness of various probiotic formulations in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 17(1):12. https://doi.org/10.1186/s13098-024-01532-w

Article  Google Scholar 

Barrea L, Annunziata G, Muscogiuri G et al (2018) Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients 10(12):1971. https://doi.org/10.3390/nu10121971

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berbudi A, Khairani S, Tjahjadi AI (2025) Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. ImmunoTargets Ther 14:359–382. https://doi.org/10.2147/ITT.S499605

Article  PubMed  PubMed Central  Google Scholar 

Brunkwall L, Orho-Melander M (2017) The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia 60(6):997–1005. https://doi.org/10.1007/s00125-017-4278-3

Article  CAS  Google Scholar 

Byndloss M, Devkota S, Duca F et al (2024) The gut microbiota and diabetes: research, translation, and clinical applications—2023 diabetes, diabetes care, and diabetologia expert forum. Diabetes Care 47(6):947–957. https://doi.org/10.2337/dci24-0052

Article  CAS  Google Scholar 

Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772. https://doi.org/10.2337/db06-1491

Article  CAS  PubMed  Google Scholar 

Canyelles M, Pérez A, Junza A et al (2022) Divergent effects of glycemic control and bariatric surgery on circulating concentrations of TMAO in newly diagnosed T2D patients and morbidly obese. Diagnostics 12(11):2783. https://doi.org/10.3390/diagnostics12112783

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caricilli AM, Saad MJA (2013) The role of gut microbiota on insulin resistance. Nutrients 5(3):829–851. https://doi.org/10.3390/nu5030829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111(6):2247–2252. https://doi.org/10.1073/pnas.1322269111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Wang J, Liu Z, Gao F (2024) Effect of supplementation with probiotics or synbiotics on cardiovascular risk factors in patients with metabolic syndrome: a systematic review and meta-analysis of randomized clinical trials. Front Endocrinol (Lausanne) 14:1282699. https://doi.org/10.3389/fendo.2023.1282699

Article  PubMed  PubMed Central  Google Scholar 

Cong J, Zhou P, Zhang R (2022) Intestinal microbiota-derived short chain fatty acids in host health and disease. Nutrients 14(9):1977. https://doi.org/10.3390/nu14091977

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dambrova M, Latkovskis G, Kuka J et al (2016) Diabetes is associated with higher trimethylamine n-oxide plasma levels. Exp Clin Endocrinol Diabetes 124(4):251–256. https://doi.org/10.1055/s-0035-1569330

Article  CAS  PubMed  Google Scholar 

De Preter V, Machiels K, Joossens M et al (2015) Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64(3):447–458. https://doi.org/10.1136/gutjnl-2013-306423

Article  CAS  PubMed  Google Scholar 

Ding LN, Ding WY, Ning J et al (2021) Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol 12:607475. https://doi.org/10.3389/fphar.2021.607475

Article  Google Scholar 

Dinicolantonio JJ, McCarty M, Okeefe J (2019) Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: Is TMAO serving as a marker for hepatic insulin resistance. Open Heart 6(2):e001040. https://doi.org/10.1136/openhrt-2019-001040

Article  Google Scholar 

Dodd D, Spitzer MH, Van Treuren W et al (2017) A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551(7682):648–652. https://doi.org/10.1038/nature24661

Article  CAS  PubMed  PubMed Central  Google Scholar 

Everard A, Belzer C, Geurts L et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110(22):9066–9071. https://doi.org/10.1073/pnas.1219451110

Article  PubMed  PubMed Central  Google Scholar 

Feng W, Yang Z, Liu Y et al (2023) Gut microbiota: A new target of traditional Chinese medicine for insomnia. Biomed Pharmacother 160:114344. https://doi.org/10.1016/j.biopha.2023.114344

Article  CAS  PubMed  Google Scholar 

Fiorucci S, Urbani G, Distrutti E, Biagioli M (2025) Obeticholic acid and other farnesoid-X-resor (FXR) agonists in the treatment of liver disorders. Pharmaceuticals 18(1):45. https://doi.org/10.3390/ph18010045

Article  CAS  Google Scholar 

Ganamurali N, Sabarathinam S (2026a) Bidirectional interplay between the gut microbiota and GLP-1 receptor agonists: towards microbiome-mediated therapeutics in type 2 diabetes mellitus. J Diabetes Metab Disord 25(1):44. https://doi.org/10.1007/s40200-025-01834-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganamurali N, Sabarathinam S (2026b) The triple-agonist revolution: retatrutide and the paradigm shift in multi-hormonal pharmacotherapy for obesity and cardiometabolic comorbidities. Clin Pharmacol Drug Dev 15:e70001. https://doi.org/10.1002/cpdd.70001

Article  CAS  PubMed  Google Scholar 

Gao Z, Yin J, Zhang J et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509–1517. https://doi.org/10.2337/db08-1637

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghafouri D (2025) The effects of probiotics, prebiotics and synbiotics on glycemic control in diabetic patients: a narrative and meta-analysis study. Int J Nutr Sci 10(1):15–28

Google Scholar 

Gonzalez JS, Peyrot M, McCarl LA et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31(12):2398–2403. https://doi.org/10.2337/dc08-1341

Article  PubMed  PubMed Central  Google Scholar 

Günther C, Rothhammer V, Karow M et al (2021) The gut-brain axis in inflammatory bowel disease—current and future perspectives. Int J Mol Sci 22(16):8870. https://doi.org/10.3390/ijms22168870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo Z, Zhang J, Wang Z et al (2016) Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep 6:20602. https://doi.org/10.1038/srep20602

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo M, Wu Y, Peng M et al (2024) Decreasing of trimethylamine N-oxide by Cecal microbiota and choline-trimethylamine Lyase are associated with Sishen pill on diarrhea with kidney-yang deficiency syndrome. J Inflamm Res 17:7275–7294. https://doi.org/10.2147/JIR.S470254

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habibi A, Letafatkar N, Sattari N et al (2025) Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: an umbrella review on meta-analyses. Clin Nutr ESPEN 65:93–104. https://doi.org/10.1016/j.clnesp.2024.11.011